Sue Cheng

Trial of Apremilast for Oral Ulcers in Behçet’s Syndrome

Gülen Hatemi, Alfred Mahr, Yoshiaki Ishigatsubo et al. · New England Journal of Medicine · 2019 · 205 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

Antibiotic research and development: business as usual?

Stephan Harbarth, Ursula Theuretzbacher, Judith Hackett et al. · Journal of Antimicrobial Chemotherapy · 2015 · 83 citations · Full text

Pharmacy, Pharmacoeconomics, Antimicrobial Resistance +12

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis

Richard J. Nowak, Michael Benatar, Emma Ciafaloni et al. · New England Journal of Medicine · 2025 · 52 citations

Life Sciences, Pharmacology, Pharmacotherapy +13

Apremilast Long-Term Safety Up to 5 Years from 15 Pooled Randomized, Placebo-Controlled Studies of Psoriasis, Psoriatic Arthritis, and Behçet’s Syndrome

Philip J. Mease, Gülen Hatemi, Maria Paris et al. · American Journal of Clinical Dermatology · 2023 · 48 citations · Full text

Life Sciences, Dermatology, Pharmacotherapy +13

Apremilast for oral ulcers associated with active Behçet's syndrome over 68 weeks: long-term results from a phase 3 randomised clinical trial

Gülen Hatemi, Alfred Mahr, Mitsuhiro Takeno et al. · Clinical and Experimental Rheumatology · 2021 · 30 citations · Full text

Medicine, Clinical Sciences, Oral Wound Healing +8